Prevention of hypertrophy by overexpression of Kv4. 2 in cultured neonatal cardiomyocytes

C Zobel, Z Kassiri, TTT Nguyen, Y Meng, PH Backx - Circulation, 2002 - Am Heart Assoc
C Zobel, Z Kassiri, TTT Nguyen, Y Meng, PH Backx
Circulation, 2002Am Heart Assoc
Background—Prolonged action potentials (APs) and decreased transient outward K+
currents (I to) are consistent findings in hypertrophic myocardium. However, the connection
of these changes with cardiac hypertrophy is unknown. The present study investigated the
effects of changes in I to and the associated alterations in AP on myocyte hypertrophy
induced by phenylephrine. Methods and Results—Chronic incubation of cultured neonatal
ventricular rat myocytes (NVRMs) with phenylephrine (PE) reduced I to density and …
Background— Prolonged action potentials (APs) and decreased transient outward K+ currents (Ito) are consistent findings in hypertrophic myocardium. However, the connection of these changes with cardiac hypertrophy is unknown. The present study investigated the effects of changes in Ito and the associated alterations in AP on myocyte hypertrophy induced by phenylephrine.
Methods and Results— Chronic incubation of cultured neonatal ventricular rat myocytes (NVRMs) with phenylephrine (PE) reduced Ito density and prolonged AP duration, leading to a 2-fold increase in the net Ca2+ influx per beat and a 1.4-fold increase in Ca2+-transient amplitude. PE treatment of chronically paced (2-Hz) NVRM also induced increases in cell size, protein/DNA ratio, atrial natriuretic factor mRNA expression, as well as β/α myosin mRNA ratio. These hypertrophic changes were associated with a 2.4-fold increase in activation of nuclear factor of activated T-cells (NFAT), indicating increased activity of the Ca2+-dependent phosphatase calcineurin. Overexpression of Kv4.2 channels using adenovirus prevented the AP duration prolongation as well as the increases in Ca2+ influx and Ca2+-transient amplitude induced by PE. Kv4.2 overexpression also prohibited the PE-induced increases in cell size, protein/DNA ratio, atrial natriuretic factor expression, β/α myosin mRNA ratio, and NFAT activation.
Conclusions— Our results demonstrate that PE-mediated hypertrophy in NRVMs seems to require Ito reductions and AP prolongation associated with increased Ca2+ influx and Ca2+ transients as well as calcineurin activation. The clinical implications of these studies and the possible involvement of other signaling pathways are discussed.
Am Heart Assoc